Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amisulpride and Ondansetron for the Prevention of PONV in Laparoscopic Surgery
NCT07891312Not yet recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Nov 2026
- Primary completion
- Jan 2028
01
Overview
Randomised, single-blind trial of amisulpride in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoint: Complete Response at 24 hours. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
amisulpride
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07891312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07891312.